Horizon Pharma reported $852.81M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Adamas Pharmaceuticals ADMS:US 21.82M 7.35M
Aerie Pharmaceuticals AERI:US $ 108.09M 14.72M
ALKERMES ALKS:US $ 383.44M 17.6M
Amgen AMGN:US $ 14585M 1716M
Antares Pharma ATRS:US $ 71.97M 0.17M
AstraZeneca AZN:LN 22222M 709M
Bristol Myers Squibb BMY:US $ 18991M 1661M
Cara Therapeutics CARA:US $ 15.17M 1.35M
Coherus Biosciences CHRS:US $ 287.05M 29.45M
Eli Lilly And LLY:US $ 15093.2M 3379M
Endo International Ordinary Shares ENDP:US $ 1409.21M 13.72M
Flexion Therapeutics FLXN:US $ 39.93M 18.05M
Horizon Pharma HZNP:US $ 852.81M 78.97M
JAZZ PHA JAZZ:US $ 880.59M 128.5M
Novartis NOVN:VX SF 29633M 527M
Pacira Pharmaceuticals PCRX:US $ 228.69M 3.39M
Perrigo Ordinary Shares PRGO:US $ 1984.5M 537.7M
Prestige Brands PBH:US $ 125.05M 2.91M
Revance Therapeutics RVNC:US $ 58.25M 7.41M
Supernus Pharmaceuticals SUPN:US $ 283.45M 42.64M
Takeda 4502:JP Y 1644766M 128410M
Teva Pharmaceutical Industries TEVA:US $ 12691M 602M
Valeant Pharmaceuticals VRX:CN $ 5517M 619M
Xeris Pharmaceuticals Inc XERS:US $ 35.46M 8.04M
Zoetis ZTS:US $ 2091M 25M